114 related articles for article (PubMed ID: 6610486)
1. The Lyt phenotype of the T cells in an antitumor adoptive transfer differs for "parent to F1" and "parent to parent" combinations.
Ahrlund-Richter L; Wikström AC; Ramqvist T; Klein E
Cell Immunol; 1984 Jul; 86(2):575-82. PubMed ID: 6610486
[TBL] [Abstract][Full Text] [Related]
2. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
3. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
Chou T; Shu S
J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
[TBL] [Abstract][Full Text] [Related]
4. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
5. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
Sakai K; Chang AE; Shu SY
Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
[TBL] [Abstract][Full Text] [Related]
6. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.
Katz IR; Lerman SP; Ponzio NM; Shreffler DC; Thorbecke GJ
J Exp Med; 1980 Feb; 151(2):347-61. PubMed ID: 6985949
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
8. The Lyt phenotype of the T cells responsible for in vivo tumor rejection in syngeneic mice.
Ozawa H; Iwaguchi T; Kataoka T
Cancer Immunol Immunother; 1986; 23(1):73-7. PubMed ID: 3533258
[TBL] [Abstract][Full Text] [Related]
9. Role of H-2 antigens in the host response to methylcholanthrene-induced tumors.
Ahrlund-Richter L; Klein E; Merino F
Immunogenetics; 1982 Jan; 15(1):53-62. PubMed ID: 6979509
[TBL] [Abstract][Full Text] [Related]
10. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
Nakayama E; Uenaka A
J Exp Med; 1985 Feb; 161(2):345-55. PubMed ID: 3871834
[TBL] [Abstract][Full Text] [Related]
11. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
[TBL] [Abstract][Full Text] [Related]
12. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
Awwad M; North RJ
J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of two monoclonal anti-Lyt-1 alloantibodies on lymphocyte distribution in vivo.
Carroll AM; de Sousa M
Immunology; 1984 Jun; 52(2):325-30. PubMed ID: 6234229
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies against murine IFN-gamma abrogate in vivo tumor immunity against RSV-induced murine sarcomas.
Prat M; Bretti S; Amedeo M; Landolfo S; Comoglio PM
J Immunol; 1987 Jun; 138(12):4530-3. PubMed ID: 3035023
[TBL] [Abstract][Full Text] [Related]
16. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.
Sugihara S; Izumi Y; Yoshioka T; Yagi H; Tsujimura T; Tarutani O; Kohno Y; Murakami S; Hamaoka T; Fujiwara H
J Immunol; 1988 Jul; 141(1):105-13. PubMed ID: 2967864
[TBL] [Abstract][Full Text] [Related]
18. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
Kern DE; Klarnet JP; Cheever MA; Greenberg PD
Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
[TBL] [Abstract][Full Text] [Related]
19. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
Shu S; Chou T; Rosenberg SA
Cancer Res; 1987 Mar; 47(5):1354-60. PubMed ID: 3102046
[TBL] [Abstract][Full Text] [Related]
20. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
Lake JP; Kapp JA; Pierce CW
J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
